Curi Bio Inc, a developer of human stem cell-based platforms for drug discovery, has raised $6 million in Series A financing. Dynamk Capital led the round.
Source: Press Release
Curi Bio lands $6m Series A
Curi Bio Inc, a developer of human stem cell-based platforms for drug discovery, has raised $6 million in Series A financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: